financetom
Business
financetom
/
Business
/
EV maker Polestar posts 40% slump in Q1 deliveries
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EV maker Polestar posts 40% slump in Q1 deliveries
Apr 11, 2024 4:28 AM

STOCKHOLM, April 11 (Reuters) - Polestar saw a

40% drop in first-quarter deliveries, the Swedish electric

vehicle (EV) said on Thursday, as the sector struggles with

slowing demand.

While automakers and suppliers are betting on future demand

for EVs, sales growth has slowed, with investment in capacity

and technology development outrunning demand, boosting pressure

on companies to cut costs.

Polestar said it delivered 7,200 vehicles in the first

quarter, down 40% from 12,076 a year earlier.

A ramp-up in deliveries of its Polestar 3 and Polestar 4 two

luxury SUVs will contribute to revenue in the latter part of the

year, CEO Thomas Ingenlath said in a statement.

"These two cars will provide the basis for a strong revenue

and margin progression during the second half of the year,

supporting our 2025 targets," Ingenlath said.

The company aims to deliver 155,000-165,000 cars in 2025.

Polestar said it had delivered 1,200 of the Polestar 4 SUV

coupe in China in the first quarter, which was the first country

to receive the car at the end of 2023.

Global deliveries of the Polestar 3 are set to begin in the

second quarter of 2024 while the Polestar 4 is expected to reach

first customers in Europe and Australia in August, with

deliveries in America expected later in the year.

Investors' enthusiasm for EV makers has cooled as growth in

sales has slowed and financial losses have piled up, making life

especially hard for start-ups like Polestar.

Financial backer Volvo Cars said in February it

would cease further funding of Polestar, which has struggled to

meet targets, and hand over most of its stake to its

shareholders such as Geely.

The company is set to report its postponed fourth-quarter

results on April 30 and first-quarter results on May 23.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Tequila maker Becle quadruples second-quarter profit
Tequila maker Becle quadruples second-quarter profit
Jul 23, 2025
MEXICO CITY, July 23 (Reuters) - Becle, the world's largest tequila producer, on Wednesday posted a second-quarter profit more than four times higher than a year earlier, hitting 2.0 billion pesos ($106.6 million), while revenues ticked up 2.8% to 11.6 billion pesos. ($1 = 18.7654 pesos at end-June) ...
ASGN Q2 Adjusted Earnings, Revenue Fall; Q3 Outlook Set
ASGN Q2 Adjusted Earnings, Revenue Fall; Q3 Outlook Set
Jul 23, 2025
05:39 PM EDT, 07/23/2025 (MT Newswires) -- ASGN ( ASGN ) reported Q2 adjusted earnings late Wednesday of $1.17 per diluted share, down from $1.36 a year earlier. Analysts polled by FactSet expected $1.08. Revenue for the quarter ended June 30 was $1.02 billion, down from $1.03 billion a year earlier. Analysts surveyed by FactSet expected $995.5 million. The company...
Viking Therapeutics Stock Slides After Company Misses Q2 Earnings Estimates
Viking Therapeutics Stock Slides After Company Misses Q2 Earnings Estimates
Jul 23, 2025
Viking Therapeutics Inc ( VKTX ) shares are falling in Wednesday’s after-hours session after the company reported financial results for the second quarter. Q2 Earnings: Viking Therapeutics ( VKTX ) reported a second-quarter loss of 58 cents per share, missing analyst estimates for a loss of 46 cents per share, according to Benzinga Pro. The clinical-stage biopharmaceutical company said research...
Copyright 2023-2026 - www.financetom.com All Rights Reserved